DRUG TRANSPORT IN THE BRAIN - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 442

60. Golden PL, Pardridge WM. 1999. P-Glycoprotein on astrocyte foot processes of unfixed
isolated human brain capillaries. Brain Res 819:143-146.
61. Schlachetzki F, Pardridge WM. 2003. P-Glycoprotein and caveolin-1alpha in endothelium
and astrocytes of primate brain. Neuroreport 14:2041-2046.
62. Bendayan R, Ronaldson PT, Gingras D, Bendayan M. 2006. In situ localization of
P-glycoprotein (ABCB1) in human and rat brain. J Histochem Cytochem 54:1159-1167.
63. Lee G, Schlichter L, Bendayan M, Bendayan R. 2001. Functional expression of
P-glycoprotein in rat brain microglia. J Pharmacol Exp Ther 299:204-212.
64. Ronaldson PT, Bendayan M, Gingras D, Piquette-Miller M, Bendayan R. 2004. Cellular
localization and functional expression of P-glycoprotein in rat astrocyte cultures.
J Neurochem 89:788-800.
65. Bendayan R, Lee G, Bendayan M. 2002. Functional expression and localization of
P-glycoprotein at the blood-brain barrier. Microsc Res Tech 57:365-380.
66. Decleves X, Fajac A, Lehmann-Che J, Tardy M, Mercier C, Hurbain I, Laplanche JL,
Bernaudin JF, Scherrmann JM. 2002. Molecular and functional MDR1-Pgp and MRPs
expression in human glioblastoma multiforme cell lines. Int J Cancer 98:173-180.
67. Jodoin J, Demeule M, Fenart L, Cecchelli R, Farmer S, Linton KJ, Higgins CF,
Beliveau R. 2003. P-Glycoprotein in blood-brain barrier endothelial cells: interaction
and oligomerization with caveolins. J Neurochem 87:1010-1023.
68. Borst P, Evers R, Kool M, Wijnholds J. 2000. A family of drug transporters: the multidrug
resistance-associated proteins. J Natl Cancer Inst 92:1295-1302.
69. Dallas S, Miller DS, Bendayan R. 2006. Multidrug resistance-associated proteins:
expression and function in the central nervous system. Pharmacol Rev 58:140-161.
70. Kruh GD, Belinsky MG. 2003. The MRP family of drug efflux pumps. Oncogene
22:7537-7552.
71. Bakos E, Evers R, Szakacs G, Tusnady GE, Welker E, Szabo K, de Haas M, van Deemter
L, Borst P, Varadi A, Sarkadi B. 1998. Functional multidrug resistance protein (MRP1)
lacking the N-terminal transmembrane domain. J Biol Chem 273:32167-32175.
72. Dallas S, Miller DS, Bendayan R. 2006. Multidrug resistance-associated proteins:
expression and function in the central nervous system. Pharmacol Rev 58:140-161.
73. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ,
Kurz EU, Duncan AM, Deeley RG. 1992. Overexpression of a transporter gene in a
multidrug-resistant human lung cancer cell line. Science 258:1650-1654.
74. Srinivas RV, Middlemas D, Flynn P, Fridland A. 1998. Human immunodeficiency virus
protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and
MRP1 but retain antiviral efficacy in cell lines expressing these transporters. Antimicrob
Agents Chemother 42:3157-3162.
75. Jones K, Bray PG, Khoo SH, Davey RA, Meaden ER, Ward SA, Back DJ. 2001.
P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4
cells: potential for accelerated viral drug resistance? AIDS 15:1353-1358.
76. Dallas S, Ronaldson PT, Bendayan M, Bendayan R. 2004. Multidrug resistance protein
1-mediated transport of saquinavir by microglia. Neuroreport 15:1183-1186.
77. van Vliet EA, Redeker S, Aronica E, Edelbroek PM, Gorter JA. 2005. Expression of
multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during
the latent period, and in chronic epileptic rats. Epilepsia 46:1569-1580.